Edition:
United States

Iovance Biotherapeutics Inc (IOVA.OQ)

IOVA.OQ on NASDAQ Stock Exchange Global Market

13.55USD
21 Sep 2018
Change (% chg)

$-0.10 (-0.73%)
Prev Close
$13.65
Open
$13.60
Day's High
$13.90
Day's Low
$13.35
Volume
597,445
Avg. Vol
263,888
52-wk High
$19.80
52-wk Low
$6.60

Chart for

About

Iovance Biotherapeutics, Inc., formerly Lion Biotechnologies, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells. The Company's lead program... (more)

Overall

Beta: 2.67
Market Cap(Mil.): $1,295.27
Shares Outstanding(Mil.): 95.59
Dividend: --
Yield (%): --

Financials

  IOVA.OQ Industry Sector
P/E (TTM): -- 108.33 32.69
EPS (TTM): -1.36 -- --
ROI: -52.63 1.50 12.72
ROE: -52.63 0.19 14.85

Earnings vs. Estimates